Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

RTI and NIDA identify first potent, selective NET ligand from 3-phenyltropane series

Nov. 27, 2000

Milestone reached in Aventis/PPD Discovery new drug development alliance

Nov. 27, 2000

Interleukin Genetics and Brigham & Women's Hospital investigate genetic control of inflammation

Nov. 15, 2000

Novartis extends R&D collaboration with Cubist

Nov. 14, 2000

Lead compound designated in Structural Bioinformatics/Yamanouchi collaboration

Nov. 14, 2000

Cambridge Drug Discovery signs drug screening agreements with Avidex and RiboTargets

Nov. 13, 2000

Gene discovery collaboration announced by Rosetta and Gemini

Nov. 10, 2000

Human antibody agreement signed by Medarex and Lilly

Nov. 9, 2000

CuraGen reports progress in Biogen research collaboration; Gemini Genomics alliance begins

Nov. 3, 2000

Karo Bio and Merck & Co. extend ER receptor drug discovery collaboration

Nov. 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...
In monkeys, enhanced TB vaccine dissolves after inducing protection
BioWorld Science
An experimental tuberculosis (TB) vaccine with a dual mission – self-destruction after inducing immunity – improved the design of the Bacillus Calmette-Guérin...
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...